Ocular Therapeutix (OCUL) Long-Term Debt Repayments (2013 - 2021)
Ocular Therapeutix's quarterly Long-Term Debt Repayments came in at $2.1 million in Q2 2021, little changed quarter-over-quarter from $2.1 million in Q1 2021.
Ocular Therapeutix has reported Long-Term Debt Repayments for 5 years, with the latest figure at $2.1 million in Q2 2021.
- For the quarter ending Q2 2021, Long-Term Debt Repayments changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2023 stood at $2.1 million (changed N/A YoY), and the FY2023 full-year result was $26.1 million, changed N/A from the prior year.
- Long-Term Debt Repayments for Q2 2021 stood at $2.1 million, roughly flat from $2.1 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $2.1 million in Q2 2021, with the low at $1.0 million in Q1 2018.
- Average Long-Term Debt Repayments over 3 years is $1.6 million, with a median of $1.5 million recorded in 2018.
- Peak annual rise in Long-Term Debt Repayments reached 20.85% in 2018, while the deepest fall reached 20.85% in 2018.
- Tracing OCUL's Long-Term Debt Repayments over 3 years: stood at $1.3 million in 2017, then rose by 18.69% to $1.5 million in 2018, then soared by 35.06% to $2.1 million in 2021.
- The last three Long-Term Debt Repayments figures came in at $2.1 million (Q2 2021), $2.1 million (Q1 2021), and $1.5 million (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Dec 31, 2018 | 1.54 Mn |
| Dec 31, 2018 | 1.54 Mn |
| Sep 30, 2018 | 1.54 Mn |
| Sep 30, 2018 | 1.54 Mn |
| Jun 30, 2018 | 1.54 Mn |
| Jun 30, 2018 | 1.54 Mn |
| Mar 31, 2018 | 1.03 Mn |
| Mar 31, 2018 | 1.03 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Jun 30, 2014 | 1.82 Mn |
| Jun 30, 2014 | 1.82 Mn |
| Mar 31, 2014 | 454,000.00 |
| Mar 31, 2014 | 454,000.00 |
| Dec 31, 2013 | 454,000.00 |
| Dec 31, 2013 | 454,000.00 |
| Sep 30, 2013 | 454,000.00 |
| Sep 30, 2013 | 454,000.00 |